Literature DB >> 20146712

New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression.

Scott M Steward-Tharp1, Yun-jeong Song, Richard M Siegel, John J O'Shea.   

Abstract

T cell-directed therapies have become mainstays in the management of various autoimmune diseases and organ transplantation. The understanding of T cell biology has expanded greatly since the development of most agents currently in use. Here we discuss important recent discoveries pertaining to T helper cell differentiation, lineage commitment, and function. Within this context, we examine existing T cell-directed therapies, including new agents being evaluated in clinical and preclinical studies. We also use recent findings to speculate on novel targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146712      PMCID: PMC2950114          DOI: 10.1111/j.1749-6632.2009.05124.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  246 in total

1.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

2.  Trichostatin A down-regulates ZAP-70, LAT and SLP-76 content in Jurkat T cells.

Authors:  Radosław Januchowski; Paweł P Jagodzinski
Journal:  Int Immunopharmacol       Date:  2006-10-17       Impact factor: 4.932

3.  Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.

Authors:  Karen Anderson; Michael Fitzgerald; Michelle Dupont; Tao Wang; Nancy Paz; Marion Dorsch; Aileen Healy; Yajun Xu; Tim Ocain; Lisa Schopf; Bruce Jaffee; Dominic Picarella
Journal:  Autoimmunity       Date:  2006-09       Impact factor: 2.815

4.  IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

Authors:  Matthew A Burchill; Jianying Yang; Christine Vogtenhuber; Bruce R Blazar; Michael A Farrar
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

5.  In SCID mice with transplanted joint tissues from rheumatism patients, a model mice of human rheumatoid arthritis, anti-human fas antibody (R-125224) distributes specifically to human synovium.

Authors:  Motoko Saito; Yasushi Yoshigae; Junichi Nakayama; Yukie Ogawa; Masahiko Ohtsuki; Atsushi Kurihara; Toshihiko Ikeda
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.200

6.  Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Authors:  Yoshiyuki Minegishi; Masako Saito; Tomohiro Morio; Ken Watanabe; Kazunaga Agematsu; Shigeru Tsuchiya; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Hideo Kaneko; Naomi Kondo; Ikuya Tsuge; Akihiro Yachie; Yukio Sakiyama; Tsutomu Iwata; Fumio Bessho; Tsutomu Ohishi; Kosuke Joh; Kohsuke Imai; Kazuhiro Kogawa; Miwa Shinohara; Mikiya Fujieda; Hiroshi Wakiguchi; Srdjan Pasic; Mario Abinun; Hans D Ochs; Eleonore D Renner; Annette Jansson; Bernd H Belohradsky; Ayse Metin; Norio Shimizu; Shuki Mizutani; Toshio Miyawaki; Shigeaki Nonoyama; Hajime Karasuyama
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

7.  A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.

Authors:  Michele Cargill; Steven J Schrodi; Monica Chang; Veronica E Garcia; Rhonda Brandon; Kristina P Callis; Nori Matsunami; Kristin G Ardlie; Daniel Civello; Joseph J Catanese; Diane U Leong; Jackie M Panko; Linda B McAllister; Christopher B Hansen; Jason Papenfuss; Stephen M Prescott; Thomas J White; Mark F Leppert; Gerald G Krueger; Ann B Begovich
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

8.  Efalizumab for severe atopic dermatitis: a pilot study in adults.

Authors:  Rodd Takiguchi; Susan Tofte; Brenda Simpson; Erin Harper; Andrew Blauvelt; Jon Hanifin; Eric Simpson
Journal:  J Am Acad Dermatol       Date:  2006-10-13       Impact factor: 11.527

9.  Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Authors:  Kim A Papp; Richard G Langley; Mark Lebwohl; Gerald G Krueger; Philippe Szapary; Newman Yeilding; Cynthia Guzzo; Ming-Chun Hsu; Yuhua Wang; Shu Li; Lisa T Dooley; Kristian Reich
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

10.  Both Th1 and Th17 are immunopathogenic but differ in other key biological activities.

Authors:  Catherine A Cox; Guangpu Shi; Hongen Yin; Barbara P Vistica; Eric F Wawrousek; Chi-Chao Chan; Igal Gery
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

View more
  13 in total

Review 1.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

2.  Cellular miR-2909 RNomics governs the genes that ensure immune checkpoint regulation.

Authors:  Deepak Kaul; Deepti Malik; Sameena Wani
Journal:  Mol Cell Biochem       Date:  2018-06-20       Impact factor: 3.396

3.  Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.

Authors:  Yuka Kobayashi; Norikazu Kiguchi; Yohji Fukazawa; Fumihiro Saika; Takehiko Maeda; Shiroh Kishioka
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

4.  Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis.

Authors:  Kjell Eneslätt; Cecilia Rietz; Patrik Rydén; Svenja Stöven; Robert V House; Lawrence A Wolfraim; Arne Tärnvik; Anders Sjöstedt
Journal:  Eur J Immunol       Date:  2011-02-21       Impact factor: 5.532

5.  The human condition: an immunological perspective.

Authors:  Ronald N Germain; Pamela L Schwartzberg
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

Review 6.  Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.

Authors:  Amosy Ephreim M'Koma
Journal:  Medicina (Kaunas)       Date:  2022-04-21       Impact factor: 2.948

Review 7.  Natural killer T (NKT) cells in autoimmune hepatitis.

Authors:  Jochen Mattner
Journal:  Curr Opin Immunol       Date:  2013-10-19       Impact factor: 7.486

8.  Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients.

Authors:  Susana G Melendreras; Pablo Martínez-Camblor; Aurora Menéndez; Cristina Bravo-Mendoza; Ana González-Vidal; Eliecer Coto; Carmen Díaz-Corte; Marta Ruiz-Ortega; Carlos López-Larrea; Beatriz Suárez-Álvarez
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

9.  Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies.

Authors:  Mathew Clement; James A Pearson; Stephanie Gras; Hugo A van den Berg; Anya Lissina; Sian Llewellyn-Lacey; Mark D Willis; Tamsin Dockree; James E McLaren; Julia Ekeruche-Makinde; Emma Gostick; Neil P Robertson; Jamie Rossjohn; Scott R Burrows; David A Price; F Susan Wong; Mark Peakman; Ania Skowera; Linda Wooldridge
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

10.  A Novel Derivative of (-)mycousnine Produced by the Endophytic Fungus Mycosphaerella nawae, Exhibits High and Selective Immunosuppressive Activity on T Cells.

Authors:  Li-Wei Wang; Jin-Liang Wang; Jing Chen; Jia-Jie Chen; Jia-Wei Shen; Xiao-Xiao Feng; Christian P Kubicek; Fu-Cheng Lin; Chu-Long Zhang; Feng-Yang Chen
Journal:  Front Microbiol       Date:  2017-07-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.